Lupus vasculitis is inflammation of blood vessel walls driven by systemic lupus erythematosus (SLE), and it affects roughly half of all people with the disease at some point in their course. It most often targets small vessels like capillaries and venules, though medium-sized arteries can be involved too, while large vessel disease is rare.1Europe PMC / MDPI Biomedicines. Lupus Vasculitis: An Overview The range of what lupus vasculitis can do spans from a patch of palpable purpura on the shins to life-threatening bleeding in the lungs or a stroke in someone under forty, and that breadth is part of what makes it both clinically important and easy to underestimate.
How Lupus Vasculitis Develops
The root of the problem is the immune system attacking blood vessel walls it should leave alone. In SLE, the body produces antibodies that bind to its own cellular debris, forming clumps called immune complexes. These complexes settle onto the inner lining of blood vessels, the endothelium, triggering a cascade of inflammation. Research has shown that immune complexes activate human endothelial cells and provoke inflammatory responses through a signaling pathway known as the HMGB1-RAGE axis, leading to the endothelial damage and inflammatory cell infiltration characteristic of lupus vasculitis.2PubMed. Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis
Another layer of damage comes from antiendothelial cell antibodies. These autoantibodies target the vessel lining directly and can cause endothelial cell death, increase the stickiness of white blood cells to vessel walls, and activate the blood clotting system, promoting vascular thrombosis on top of the inflammation.3PubMed Central. Antiendothelial cell antibodies in vasculitis and connective tissue disease This dual assault, immune complexes from the outside and autoantibodies targeting the endothelium directly, helps explain why lupus vasculitis can affect so many different organs and why the damage it causes is sometimes inflammatory and sometimes thrombotic, or both at once.
Complement activation adds fuel to the process. In lupus patients followed over time, blood levels of complement fragments like C3a rise well before a clinical flare becomes obvious. One study found that the average C3a level roughly tripled during disease flares compared to stable periods, and elevations were detectable one to two months before symptoms worsened.4PubMed. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis These complement fragments can themselves injure blood vessel walls, creating a self-reinforcing loop of inflammation.
Skin and Extremity Involvement
The skin is the most frequently affected organ in lupus vasculitis, and the hallmark sign is palpable purpura: raised, non-blanching reddish-purple spots that you can feel with your fingernails. These reflect leukocytoclastic vasculitis, a pattern in which white blood cells invade and destroy tiny blood vessels in the skin. A case report in a patient with newly diagnosed SLE described extensive tender palpable purpura across the arms, legs, and torso, along with inflammatory papules and nodules over the cheeks and nose.5The American Journal of Managed Care. Case Report Details Rare Case of SLE With Cutaneous Leukocytoclastic Vasculitis Cutaneous vasculitis can also show up as urticarial lesions, livedo reticularis (a net-like purplish discoloration), or painful ulcers, particularly on the lower legs.
At the extreme end of skin and extremity involvement is digital gangrene, where fingers or toes lose blood supply and tissue starts to die. This complication is rare but devastating. A large cohort study of over 2,600 lupus patients admitted to a single center over a decade identified eighteen who developed digital gangrene, with the average age at the time being around 33 and the average disease duration about eight years.6PubMed. Prevalence, risk factors and outcome of digital gangrene in 2684 lupus patients The poor blood flow behind digital gangrene can result from vasculitis itself, but also from vasospasm, blood clots, or accelerated atherosclerosis, and often from more than one of these at the same time.7PubMed Central. Peripheral Gangrene as the Initial Presentation of Systemic Lupus Erythematosus in Emergency Department In some cases, digital gangrene is actually the first sign that leads to a lupus diagnosis.
Acute digital ischemia, where a finger or toe suddenly turns cold, painful, and discolored, represents an emergency that requires aggressive treatment. A recent case report described successful treatment of acute digital ischemia from lupus vasculitis using anifrolumab, a newer biologic that blocks interferon signaling, suggesting that the treatment landscape for these crises may be expanding.8PubMed. Acute digital ischemia due to lupus vasculitis successfully treated with anifrolumab
When the Gut Is Involved
Lupus mesenteric vasculitis, inflammation of the blood vessels supplying the intestines, is considered the primary cause of acute abdominal pain in people with SLE. It typically comes on suddenly, with severe, diffuse abdominal pain that can mimic a surgical emergency like appendicitis or a bowel obstruction.9PubMed. Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE Nausea, vomiting, diarrhea, and abdominal bloating are common accompaniments. If the inflammation progresses unchecked, the intestinal wall can lose its blood supply entirely, leading to bowel ischemia, tissue death, or perforation, all of which are surgical emergencies with high mortality.
The key to managing mesenteric vasculitis is recognizing it early and starting high-dose intravenous corticosteroids promptly. CT imaging often reveals a characteristic pattern of bowel wall thickening, mesenteric vessel engorgement, and sometimes the so-called “target sign” in dilated bowel loops. When steroid therapy alone is not enough to control the inflammation, cyclophosphamide given as intravenous pulses has been used as a rescue strategy. One report described a patient whose gastrointestinal vasculitis relapsed despite high-dose prednisone but went into sustained remission after pulse cyclophosphamide, with the authors recommending early escalation when steroids fail.10British Journal of Rheumatology. Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide
Effects on the Brain and Nerves
Central nervous system vasculitis in lupus tends to affect the endothelium of small and medium arteries through a pattern of concentric perivascular inflammation, which differs from the eccentric plaque damage seen in typical atherosclerosis.11PubMed Central. Stroke in the Young: A Case of CNS Vasculitis Secondary to Systemic Lupus Erythematosus The practical consequence is that lupus patients, especially those under fifty, face a meaningfully higher risk of stroke than the general population. The same study reported a hazard ratio of 2.2 for ischemic stroke and 1.4 for brain hemorrhage in SLE patients compared to the general population. For young adults, that elevated stroke risk is especially concerning because lupus is not on most emergency physicians’ radar when someone in their twenties or thirties presents with sudden neurological deficits.
CNS vasculitis in lupus can cause headaches, seizures, cognitive dysfunction, psychosis, and focal neurological deficits depending on which vessels are involved. The presentation is notoriously difficult to distinguish from other causes of neuropsychiatric lupus, such as antibody-mediated neuronal injury or thrombotic events from antiphospholipid antibodies. Advanced brain imaging and sometimes cerebrospinal fluid analysis are needed to make the diagnosis with confidence.
The peripheral nervous system is not spared either. Lupus vasculitis can cause mononeuritis multiplex, a condition where individual nerves in different parts of the body lose function in an asymmetric, patchy pattern. A case report described a 47-year-old woman with lupus whose first sign of peripheral nerve vasculitis was painful feet, eventually diagnosed as mononeuritis multiplex.12Europe PMC / CMAJ. Painful feet as the presenting symptom of mononeuritis multiplex in a 47-year-old woman with systemic lupus erythematosus The spectrum of involvement, from mild cutaneous disease to single-organ problems to multisystem crises, is one of the defining features of lupus vasculitis.13Europe PMC / MDPI Biomedicines. Lupus Vasculitis: An Overview
Kidney and Lung Complications
The kidneys in lupus can be damaged by vasculitis through a specific pattern called thrombotic microangiopathy, where tiny blood vessels in the kidney become clogged with clots and damaged endothelium. In a study of 148 patients with lupus nephritis, about a quarter had coexisting thrombotic microangiopathy on biopsy. Most of these had isolated kidney involvement rather than a systemic clotting disorder, though a small number had associated conditions like antiphospholipid syndrome or malignant hypertension.14PubMed Central. The spectrum of renal thrombotic microangiopathy in lupus nephritis Having thrombotic microangiopathy alongside lupus nephritis tends to mean worse kidney function at diagnosis: patients have higher creatinine, more protein in the urine, lower blood counts, and more chronic scarring on biopsy compared to those with lupus nephritis alone.15PubMed Central. Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis
In the lungs, the most feared vasculitic complication is diffuse alveolar hemorrhage, where inflammation of the small pulmonary blood vessels causes bleeding into the air sacs. Patients typically present with sudden breathlessness, a drop in hemoglobin, and new infiltrates on chest imaging, sometimes with coughing up blood but not always. Biopsy studies have identified both an inflammatory form with capillaritis and a bland, non-inflammatory form, which complicates the clinical picture because the treatment approach can differ.16PubMed Central. Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies Diffuse alveolar hemorrhage remains one of the most serious acute events in lupus, with mortality historically running high despite aggressive treatment.
Telling Vasculitis Apart from Thrombosis
One of the trickiest diagnostic challenges in lupus is figuring out whether blood vessel damage is caused by vasculitis (inflammation of the vessel wall) or by thrombosis (clotting inside the vessel), because the two processes look different under the microscope and call for fundamentally different treatments. Antiphospholipid syndrome, which overlaps with lupus in a substantial fraction of patients, causes vascular problems primarily through clotting rather than inflammation. A diagnosis of vasculitis points toward immunosuppressive drugs like corticosteroids and cyclophosphamide, while antiphospholipid-driven thrombosis responds to anticoagulation with blood thinners. Getting this distinction wrong, treating thrombosis with immunosuppressants or vasculitis with anticoagulants alone, can be genuinely dangerous.17PubMed. Vasculitis in antiphospholipid syndrome
The vasculopathy of antiphospholipid syndrome is almost exclusively thrombotic rather than inflammatory, even though the two can coexist in the same patient when lupus is the underlying disease.18PubMed. Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort This means a lupus patient with antiphospholipid antibodies and a new vascular event could have vasculitis, thrombosis, or both, and the clinical team has to sort out which is driving the damage before choosing therapy.
A separate overlap worth knowing about involves antineutrophil cytoplasmic antibodies, the markers typically associated with a different family of vasculitis. Lupus patients occasionally test positive for these antibodies, and rarely, true overlap between lupus nephritis and ANCA-associated vasculitis occurs. The kidney biopsy findings in these two diseases are usually distinct: ANCA vasculitis shows very few immune deposits with lots of crescent formation, while lupus nephritis classically shows heavy, “full-house” immune deposits.19PubMed Central. Systemic Lupus Erythematosus and ANCA-Associated Vasculitis Overlap Syndrome: A Case Report When a lupus kidney biopsy shows a disproportionate number of crescents, checking for ANCA overlap becomes important because it changes treatment decisions. That said, simply finding ANCA positivity in a lupus patient does not by itself confirm overlap syndrome; it often has no clinical significance.20PubMed Central. Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis
Treatment Approaches
The backbone of lupus vasculitis treatment remains corticosteroids, usually started at high doses and given intravenously in severe cases. For mild cutaneous vasculitis, moderate oral corticosteroid courses combined with antimalarial drugs like hydroxychloroquine often suffice. When the vasculitis threatens organs, treatment escalates to immunosuppressive agents. Cyclophosphamide, either as intravenous pulses or in oral form, has been the traditional escalation therapy for decades, particularly for mesenteric vasculitis that does not respond to steroids, for CNS vasculitis, and for diffuse alveolar hemorrhage.
Rituximab, a biologic that depletes B cells, has emerged as an option for refractory lupus including cases complicated by vasculitis. In a study comparing rituximab outcomes in patients with SLE and those with ANCA-associated vasculitis, all eleven lupus patients responded to treatment, with six achieving complete remission and five a partial response. All six who had kidney involvement showed improvement. However, relapse was common, occurring in about two-thirds of lupus patients after B cell levels recovered, and retreatment with rituximab was effective for those who relapsed.21PubMed. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment
For patients with refractory disease who have not responded to standard immunosuppression, plasma exchange and immunoadsorption are used as rescue strategies. Plasma exchange physically removes circulating immune complexes and autoantibodies from the blood, and reports have shown benefit in patients with severe, treatment-resistant lupus.22Elsevier / Autoimmunity Reviews. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review These are not first-line therapies but can be life-saving when standard approaches fail or when immunosuppression is contraindicated, such as during pregnancy.
Lupus Vasculitis in Children and Adolescents
Juvenile-onset lupus tends to be more aggressive than adult-onset disease, and vasculitis is part of that picture. In children and teens with SLE, vasculitis more often presents as skin involvement than visceral organ disease, though it can affect the central and peripheral nervous systems, lungs, gut, kidneys, and heart.23PubMed Central. Vasculitis in Juvenile-Onset Systemic Lupus Erythematosus
Mesenteric vasculitis as an initial presentation of childhood lupus deserves particular attention. A case-control study found that children presenting with lupus mesenteric vasculitis, with an average onset age around twelve or thirteen, had high disease activity overall and were more likely to have concurrent kidney, lung, and serous cavity involvement compared to pediatric lupus patients without mesenteric vasculitis. Abdominal pain was the most common symptom, followed by vomiting, bloating, and diarrhea.24PubMed Central. Clinical characteristics and prognosis of childhood-onset lupus mesenteric vasculitis as the initial presentation-a case-control study The challenge for pediatricians is that abdominal pain in a twelve-year-old has a long differential diagnosis, and lupus mesenteric vasculitis may not be on the list unless the child already carries an SLE diagnosis.
Drug-Induced Vasculitis as a Complicating Factor
An increasing number of medications have been linked to drug-induced vasculitis, typically affecting small vessels and sometimes mimicking or worsening lupus vasculitis. The pattern usually involves capillaries, venules, and arterioles in a leukocytoclastic picture, or occasionally a pattern resembling ANCA-associated disease or polyarteritis. Withdrawal of the offending drug is the primary treatment, and early recognition can prevent severe organ damage.25PubMed Central. Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects For lupus patients who are often on multiple medications, this creates a practical diagnostic puzzle: when vasculitis flares, is it the disease progressing or a medication reaction? The distinction matters because one scenario calls for more immunosuppression and the other for stopping a drug.
Monitoring Small Vessel Damage
One area of growing interest is the use of nailfold capillaroscopy, a simple, noninvasive technique that examines the tiny blood vessels at the base of fingernails under magnification, to track microvascular injury in lupus. Microvascular damage is central to SLE pathology, and capillaroscopy can visualize this damage in real time, potentially linking visible capillary abnormalities to disease activity, autoantibody profiles, and the risk of digital ischemia.26Clinical Rheumatology. The microvascular footprint of lupus: nailfold capillaroscopy findings in Egyptian SLE patients and their link to disease activity, autoantibodies, and digital ischemia The appeal of capillaroscopy is that it is cheap, painless, and repeatable, making it a candidate for longitudinal monitoring rather than relying solely on blood tests and biopsies that capture only a snapshot. Whether it proves useful enough to change clinical decisions on a routine basis remains an open question, but the concept of watching lupus vasculitis in real time through a bedside microscope is a compelling one.